Today, August 31st, is International Overdose Awareness Day. The annual campaign, started in 2001, is part of a global movement to end overdoses, end stigma surrounding drug use, and to acknowledge the grief of the families and friends who’ve lost loved ones to drug overdoses.
The BC-CfE’s Laboratory and its Director, Dr. Zabrina Brumme, are celebrating another recent success in being awarded grant funding for research. The BC-CfE, along with frequent collaborating partner Simon Fraser University, are now a part of the U.S.-based Research Enterprise to Advance a Cure for HIV (REACH) Collaboratory.
New research led by the BC-CfE’s Dr. Viviane Dias Lima examines how sexually risky behavior is linked to mood or anxiety disorders among lesbian, gay, and bisexual people in BC.
The 11th International AIDS Society (IAS) Conference on HIV Science took place from July 18th to the 21st and BC-CfE researchers attending the virtual conference used the opportunity to present their latest findings.
The BC-CfE supports the recent decision by the Government of BC to phase in a new policy expanding access to prescribed safer drug supply.
It’s been a busy summer for Rachel Miller, a graduate student in the BC-CfE’s Molecular Epidemiology and Evolutionary Genetics Group. Miller won a scholarship to attend the 23rd annual International AIDS Conference and she also won a prestigious award for the abstract she’ll be presenting at the conference.
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below
